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Abstract. RNA polymerase I preparations purified from a 
rat hepatoma contained DNA topoisomerase activity. The 
DNA topoisomerase associated with the polymerase had 
an Mr of 110000, required Mg2+ but not ATP, and was 
recognized by anti-topoisomerase I antibodies. When added 
to RNA polymerase I preparations containing topoisomer-
ase activity, anti-topoisomerase I antibodies were able to 
inhibit the DNA relaxing activity of the preparation as well 
as RNA synthesis in vitro. RNA polymerase II prepared 
by analogous procedures did not contain topoisomerase ac-
tivity and was not recognized by the antibodies. The topo-
isomerase I: polymerase I complex was reversibly disso-
ciated by column chromatography on Sephacryl S200 in 
the presence of 0.25 M (NH4hS04. Topoisomerase I was 
immunolocalized in the transcriptionally active ribosomal 
gene complex containing RNA polymerase I in situ. These 
data indicate that topoisomerase I and RNA polymerase I 
are tightly complexed both in vivo and in vitro, and suggest 
a role for DNA topoisomerase I in the transcription of ribo-
somal genes. 
Introduction 
The DNA topoisomerases are a group of enzymes with 
the ability to interconvert topological isomers of DNA by 
breaking and resealing phosphodiester bonds (for recent 
reviews see Liu 1984 ; Vosberg 1985 ; Wang 1985). Type I 
topoisomerase, first described in prokaryotes by Wang 
(1971) and in eukaryotes by Champoux and Dulbecco 
(1972) and later characterized by Keller (1975a, b), change 
the linking number in steps of one. Although their biologi-
cal function is not completely defined , this class of topo-
isomerase has been implicated in transcriptional (Akrigg 
and Cook 1980; Dynan and Burgess 1981; Sternglanz et al. 
1981; Weisbrod 1982; Fleischmann et al. 1984 ; Gilmour 
et al. 1986; Shastry 1986) as well as in recombinational 
and replicational (Kikuchi and Nash 1979 ; Sternglanz et al. 
1981 ; also see Gellert 1981 ; Bullock et al. 1985 ; Zeng et al. 
1985) events. J n higher eukaryotes topoisomerase I is en-
riched in the nucleolus (Fleischmann et al. 1984; Muller 
et al. 1985) and may play a role in transcription of super-
coiled rDNA in vitro (Garg et al. 1987). Studies in Tetrahy-
mena indicate that the ribosomal DNA-associated enzyme 
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is located at DNase I hypersensitive sites in the nontran-
scribed rDNA spacer region (Bonven et al. 1985). In vitro 
the activity of topoisomerase I is inhibited by polyADP-
ribosylation (Jonstra-Bilen et al. 1983; Ferro and Olivers 
1984). Conversely, the activity is stimulated when the en-
zyme is phosphorylated by casein kinase IT (Durban et a l. 
1985). 
The DNA-dependent enzyme, RNA polymerase I, is re-
sponsible for the transcription of ribosomal genes (for re-
views see Roeder 1976 ; Jacob and Rose 1978). This poly-
merase is associated with actively transcribed nucleolar 
genes and is localized in the fibrillar center of that organelle 
(Scheer and Rose 1984). Further, RN A polymerase I is 
phosphorylated by a type 11 casein kinase, nuclear protein 
kinase NIl (Rose et al. 1981 a, b), and this modification en-
hances transcription (Duceman et al. 1981 ; Rose et al. 
1983). Taken together with the observations concerning to-
po isomerase I these data suggest an intriguing relationship 
between topoisomerase I and RNA polymerase I. We now 
wish to report that a topoisomerase I activity is reversibly 
associated with highly purified preparations of RNA poly-
merase I and that inhibition of the topoisomerase activity 
of the complex inhibits transcription. Further, topoisomera-
se I is shown to be present in the active ribosomal gene 
transcription complex in situ. 
Materials and methods 
Enzyme purification. RNA polymerase I was purified by se-
quential column chromatography on DEAE-Sephadex, 
Affi-gel Blue and heparin-Sepharose followed by sedimen-
tation on sucrose gradients essentially as described pre-
viously (Rose et al. 1981 a) except that 25% glycerol was 
included and 0.2- 0.25 M (NH4)2S04 sometimes replaced 
KCl in the sucrose gradient buffer (sedimentation time was 
increased to 16 h to accommodate the increased viscosity 
of the grad ient). Purified RNA polymerase I had a specific 
activity of 100 nmol UMP incorporated in 30 min per milli-
gram protein measured under optimal conditions (Rose 
et al. 1976). Topoisomerase I was obtained from the sucrose 
gradient of the polymerase preparation. Fractions that sedi-
mented from approximately 7- 10 S were pooled and puri-
fied in a manner analogous to that described for protein 
kinase NIl (Rose et al. 1981 a). The final step in the purifi-
cation, ATP-Sepharose chromatography, separated the re-
maining protein kinase from the topoisomerase, which 
eluted in the flow-through fractions. Purified topoisomerase 
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had a specific activity of 150000 units per milligram protein. 
One unit represents the capacity to relax 1 Ilg supercoiled 
DNA in 30 min at 37° C. 
Topoisomerase assay. Reactions (26 III final volume) con-
tained 5 mM MgCI 2 , 0.1 mM EDTA, 25 mM KCI, enzyme 
diluted in buffer containing final concentrations of 0.2 mM 
dithiothreitol, 20 mM Tris-CI, pH 7.9, 20% glycerol, and 
160 ng pBR322 DNA (obtained from BRL, approximately 
75% in the supercoiled form). Following incubation for 
45 min at 37° C, reactions were terminated by addition of 
1 III of solution containing 1 % sodium dodecyl sulfate, 
0.25% xylene cyanol, 0.25% bromophenol blue and 30% 
glycerol. Samples were loaded onto a 0.5% agarose gel and 
electrophoresis was carried out at 30 V for 16 h at 23° C 
in buffer containing 40 mM Tris-acetate, pH 8, 1 mM 
EDT A. Following electrophoresis, the gels were immersed 
in ethidium bromide solution (40 ng/ml) for 30 min and 
destained in H 20 for 1- 2 h. DNA was visualized with a 
Photodyne 3- 3000 UV transilluminator. In those instances 
in which electrophoresis was conducted in the presence of 
ethidium bromide (relaxation assay), the intercalating agent 
was included in the running buffer at a concentration of 
20 ng/ml. To enhance visualization, these gels were also 
immersed in ethidium bromide following electrophoresis. 
Data were quantitated by laser beam densitometry. 
RNA polymerase assay and immunoblotling. RNA synthesis 
was measured as described previously (Szopa and Rose 
1986). Immunoblotting was also conducted as described 
therein. 
Anti-topoisomerase antibodies. Monoclonal antibodies 
against human topoisomerase I were prepared by a modifi-
cation of the technique described by K6hler and Milstein 
(1975). A complete description of the protocol will be pre-
sented elsewhere (F.S. Han and y-c. Cheng, in prepara-
tion). Antibodies were purified by DEAE-Affi gel Blue or 
protein A-Sepharose chromatography and dialyzed into 
buffer containing 0.1 M Tris-Cl, pH 7.4. Polyclonal anti-
bodies were prepared by immunization of rabbits with topo-
isomerase I purified from calf thymus. Immunoglobulins 
were purified by protein A-Sepharose chromatography. 
Monospecific antibodies were prepared by elution with 
10 mM Hepes, pH 2.8 (Fleischmann et al. 1984) from im-
munoblots of topoisomerase I. 
Immunofluorescence microscopy. An established rat cell line 
(RV-SMC) was prepared for immunofluorescence micros-
copy as described (Scheer and Rose 1984). The cells were 
incubated with affinity purified rabbit antibodies to topo-
isomerase I (15 Ilg/ml in PBS for 20 min at room tempera-
ture), washed several times in PBS followed by incubation 
with FITC-labeled anti-rabbit IgG diluted 1: 20 (Dianova, 
Hamburg, FRG). In some experiments cells were exposed 
for 6 h to 50 Ilg/ml 5,6-dichloro-D-ribofuranosylbenzimida-
zole (DRB) (Scheer et al. 1984) prior to immunostaining. 
Results 
First we evaluated whether topoisomerase activity was pres-
ent in purified RNA polymerase preparations. As shown 
in Figure 1, a highly purified polymerase I fraction isolated 
from sucrose gradients performed in 0.3 M KCI was able 
to change the linking number of superhelical (form I) DNA. 
This activity was dependent on both enzyme concentration 
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Fig. L Topoisomerase activity associated with purified RNA poly-
merase I. RNA polymerase I was purified through sucrose gra-
dients and analyzed for to po isomerase activity as describcd in Ma-
terials and methods. Lanes 1- 3, products obtained from reactions 
containing 165, 247, and 330 ng of RNA polymerase I, respectively, 
incubated for 45 min at 37° C. Lanes 4-6, DNA from reactions 
containing 330 ng of polymerase I, incubated at the same tempera-
ture for 0, 10, and 30 min , respectively. Lanes 7- 9, products from 
reactions containing 500 pg topoisomerase purified as described 
in Materials and methods and incubated for 45 min at 37° C under 
normal reaction conditions (lane 7), and the absence of MgCI2 
(lane 8), or in the presence of 0.5 mM ATP (lane 9). Lane 10, DNA 
incubated in the absence of enzyme. I and 11 , supercoiled form 
I and open circular form Il DNAs, respectively 
(Fig. 1, lanes 1- 3) and time (lanes 4-6). The actIvIty re-
quired Mg + + but not ATP and was stimulated in the pres-
ence of 25- 50 mM KCI (not shown). 
To compare this activity with that of a pure topoisomer-
ase, we isolated a topoisomerase independent of RNA poly-
merase. Preliminary experiments indicated that the bulk of 
the ATP-independent topoisomerase activity in the nuclear 
extracts used for purification of RNA polymerase I copuri-
fied with this polymerase. The last step in polymerase I 
purification is sedimentation through sucrose gradients in 
the presence of 0.3 M KCI (Rose et al. 1981 a) or 0.25 M 
(NH4hS04 (for optima l release of associated polypeptides). 
Because of the large size of the polymerase ( > 15S) and 
the presence of the salt this step is efficient in the removal 
of enzyme-bound polypeptides. Thus, the upper fractions 
of the gradient can be used for the further purification of 
proteins that have an affinity for the enzyme but are re-
leased by the high salt and/or by the shear forces of the 
gradient as well as for purification of enzyme subunits that 
have "disassembled" during the gradient stage. Topo-
isomerase I was purified from the fractions of the gradient 
containing both protein kinase NIl (approximately 6-7S; 
Rose et al. 1981 a) and topoisomerase activi ties. The topo-
isomerase copurified with the kinase through the casein-
and phosvitin-Sepharose columns but, unlike the kinase, 
was not retained on the ATP-Sepharose columns. The puri-
fied topoisomerase activity was dependent on both time 
and enzyme concentration (not shown) and required Mg + +, 
but not A TP (Fig. 1, lanes 7- 9). 
The purified topoisomerase appeared to be a single po-
lypeptide with an Mr of 110000 as estimated by analysis 
on polyacrylamide gels in the presence of sodium dodecyl 
sulphate (Fig. 2, lane 1). The size of this topoisomerase, 
coupled with its enzymatic properties suggested that it was 
a type I topoisomerase. To confirm this, the purified en-
zyme was analyzed by immunoblotting using monoclonal 
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Fig. 2. Immunoblotting of topoisomerase I and RNA polymerase I. 
Topoisomerase I and RNA polymerase I were purified as described 
in Material and methods and subjected to linear polyacrylamide 
gradient (4.5%- 12.5%) gel electrophoresis essentially as described 
by Laemmli (1970). Lane 1, topoisomerase I , 1 ~g, stained with 
Coomassie Blue ; lane 2, RNA polymerase t, 70 ng, stained with 
silver. Proteins from analogous gels were transferred to nitrocellu-
lose and reacted with anti-topoisomerase antibodies (lanes 3 and 
4) as described in Materials and mcthods. Lane 3, topoisomerase I 
(1 ~g); lane 4, RNA polymerase I (10 ~g) 
antibodies against topoisomerase 1. As shown in Figure 2, 
lane 3, the antibodies recognized the 110000 M, polypep-
tide. Two smaller polypeptides, not visible on the protein-
stained gel, were also detected on the immunoblots ; pre-
sumably these were cleavage products since they are not 
observed in freshly prepared enzyme preparations (see also 
Schmitt et al. 1984; Guldner et al. 1986 ; Shero et al. 1986). 
To evaluate whether RNA polymerase I preparations con-
tained a similar topoisomerase they were analyzed in an 
analogous manner. As indicated in Figure 2, lane 2, purified 
RNA polymerase I purified on sucrose gradients containing 
0.3 M KCI contains several polypeptides; most evident are 
those of M, 190000 and 11 0000. The minor bands shown 
in this gel are degradation products of the M, 190000 poly-
peptide. When larger quantities of the enzyme are applied 
to the gel, the smaller polypeptides, (M,65000, 42000, 
25000) associated with the polymerase, can be visualized. 
As shown in Figure 2, lane 4, the monoclonal antibodies 
against topoisomerase I reacted with an M, 110000 poly-
peptide of the RNA polymerase I preparation. As an aside 
it should be mentioned that RNA polymerase II purified 
by methods analogous to polymerase I neither contained 
topoisomerase activity nor reacted with the anti-topo-
isomerase antibodies on immunoblots (not shown). A re-
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cent report based on in vivo crosslinking has also provided 
evidence that RNA polymerase II and topoisomerase I are 
not tightly associated but interact independently with tran-
scribed sequences (Gi lmour et al. 1986). 
To evaluate whether the association between RNA poly-
merase I and topoisomerase had any functional signifi-
cance, we examined RNA synthesis in the presence of the 
anti-topoisomerase antibodies. We chose a range of anti-
body concentrations that were capable of preventing the 
conversion of negatively super-coiled DNA to the relaxed 
form . As can be seen in F igure 3, lanes 3- 7, in the presence 
of the antibodies, the topoisomerase activity in the polymer-
ase preparation was able to open the negatively super-coiled 
DNA, but not to reseal it. It should be noted that inhibition 
of an equivalent amount of relaxing activity of the purified 
topoisomerase (separated from polymerase) required less 
antibody (Fig. 3, lane 14). Whether the need to use more 
antibodies to inhibit the polymerase I-associated enzyme 
reflected the presence of inactive topoisomerase molecules 
or restricted access of the antibodies to their binding sites 
as a result of association of the topoisomerase with the 
polymerase is not known . In a separate experiment we ex-
amined the effect of the topoisomerase antibodies on RNA 
synthesis. As shown in Figure 4, RNA polymerase I activity 
was inhibited by the topoisomerase antibodies. Similar con-
centrations of immunoglobulins purified from normal 
mouse serum had no effect on RNA synthesis. Using the 
same anti-topoisomerase antibody preparation, inhibition 
of the purified topoisomerase was also observed. As had 
been observed in Figure 3, it required less antibody to inhib-
it the isolated topoisomerase activity. To evaluate whether 
the to po isomerase was tightly bound to the polymerase, 
we immobilized anti-topoisomerase antibodies on DEAE 
Affi-gel Blue or protein A-Sepharose beads, and added 
them to RNA polymerase I. In two different experiments, 
beads containing the anti-topoisomerase I antibodies re-
moved 45%- 47% of the polymerase I activity from solu-
tion, whereas beads containing control immunoglobulins 
removed less than 5% of the enzyme activity. To determine 
whether the antibody-induced inhibition of RNA polymera-
se I was nonspecific, we added topoisomerase I to RNA 
polymerase II and then added the anti-topoisomerase anti-
bodies ; no inhibition was observed in this case. 
The foregoing suggested that polymerase J and topo-
isomerase I formed a complex in vitro . To ascertain whether 
this was a reversible complex we tried to dissociate the 
enzymes by gel filtration chromatography under various 
salt conditions. Initial experiments suggested that the 
M, 11 0000 topoisomerase coeluted with the M,500000-
600000 polymerase at NaCI or NH4Cl concentrations up 
to 0.8 M. However, when 0.25 M (NH4hS04 was used as 
the salt the enzymes could be dissociated into separately 
eluting entities (Fig. 5A). The polymerase I: topoisomera-
se I complex was completely reversible and the enzymes 
in the reconstituted complex coeluted at 20 mM (NH4hS04 
(Fig. 5 B). For comparison, the elution profiles of the disso-
ciated enzymes individually subjected to chromatography 
at 20 mM (NH4)2S04 are shown in Figure 5C (topoisomer-
ase) and D (polymerase). Note that at 20 mM (NH4hS04, 
the topoisomerase alone does not aggregate and elutes at 
the same elution volume as under the 0.25 M (NH4)2S04 
conditions. 
Using immunocytochemical methods, we have pre-
viously den'lonstrated the presence of RNA polymerase I 
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Fig. 3. Inhibition of topoisomerase activity by anti-topoisomerase antibodies. RNA polymerase I (260 ng) or topoisomerase I (500 pg) 
were preincubated with anti-topoisomerase antibodies for 20 min at 30° C in buffer containing 40 mM Tris-CI, pH 7.5, 5 mM MgCI 2, 
0.1 mM EDTA. DNA was then added and the reactions incubated for 45 min at 37° C. Reactions were terminated by addition of 
sodium dodecyl sulfate (0.5% final concentration). Following incubation in the presence of 2 x 10 - 3 units of proteinase K for 15 min 
a t 37° C, reaction products were processed on 0.5% agarose gels containing 0.02 Ilg/ml ethidium bromide as described in Materials 
and methods. Lanes 1, 13 and 16, DNA processed in the absence of enzyme. Lanes 2- 12, RNA polymerase I. Lanes 14, 15, topoisomerase l. 
Lanes 3- 7, RNA polymerase incubated in the presence of 3.85,1.92,0.96,0.48, and 0.24 Ilg anti-topoisomerase IgG, respectively. Lanes 8-
12, enzyme incubated in the presence of identical concentrations of normal mouse IgG. Lanes 13, 16, DNA incubated in the presence 
of 1.70 Ilg normal mouse IgG . Lanes 14, 15, topoisomerase incubated with 0.24 Ilg anti-topoisomerase and normal mouse IgG, respectively. 
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Fig. 4. Effect of anti-topoisomerase antibodies on RNA synthesis. 
RNA polymerase I was preincubated for 5 min at 30° C with anti-
topoisomerase antibodies as indicated. RNA synthesis was then 
measured by incubation with DNA and appropriate co factors as 
described (Szopa and Rose 1986) (e). In a parallel experiment, 
the antibodies were preincubated with topoisomerase I purified 
from the hepatoma and topoisomerase activity measured, and con-
version of form I to form II DNA quantitated by laser beam densit-
ometry (0). Addition of 15-40 Ilg of normal mouse immunoglobu-
Iins purified in an analogous manner to the anti-topoisomerase 
antibodies had no effect on either RNA synthesis or topoisomerase 
activity 
in the active ribosomal gene transcription complex (Scheer 
and Rose 1984 ; Scheer et al. 1984). To investigate whether 
topoisomerase] is associated with ribosomal genes in situ 
we examined the localization of topoisomerase I in an es-
tablished rat cell line. As shown in Figure 6A, B, affinity 
purified rabbit polyclonal antibodies raised against topo-
isomerase I stained the nucleoli of these cells very strongly. 
fn addition, the whole nucleoplasm was stained in a finely 
punctate pattern. In cells treated with DRB, the nucleolar 
architecture is disrupted (Fig. 6C) and the RNA-containing 
chromatin extended (Scheer et al. 1984). In spite of this, 
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Fig. SA-D. Reversible dissociation of RNA po lymerase and topo-
isomerase: analysis by gel filtration chromatography. A 300 III 
sample containing the RNA polymerase: topoisomerase complex 
or the individual enzymes was applied to a 0.75 x 26 cm Sephacryl 
S200 column equilibrated in buffer containing 50 mM Hepes-CI , 
pH 7.9,25% glycerol, 0.1 mM EDTA, 0.5 mM dithiothreitol and 
either 0.25 M (NH4)2S04 (A) or 20 mM (N H4)2S04 (B-D). The 
column was developed with the same buffer, 0.8 ml fractions col-
lected and enzyme aliquots analyzed for RNA polymerase (e ) or 
topoisomerase (0) activity. A RNA polymerase I containing topo-
isomerase, obtained from the heparin Sepharose stage of purifica-
tion , was adjusted to a final concentration of 0.25 M (NH 4hS04 
prior to column application. B-D RNA polymerase I and topo-
isomerase I previously separated were either recombined (8) or 
separately (C, topoisomerase; D RNA polymerase) concentrated 
and then dialyzed for 3 h against buffer containing 20 mM 
(NH4hS04 
ribosomal RNA synthesis proceeds at approximately 80% 
of the normal rate and the actively transcribed genes can 
be visualized as a beaded structure using anti-RNA poly-
merase I antibodies and indirect immunofluorescence 
(Scheer et al. 1984). Thus treatment of cells with ORB al-
lows precise localization of ribosomal gene transcription 
units at the level of light microscopy. Therefore we exam-
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Fig.6A-D. Immunocytochemical localization of topoisomerase I. Rat cells were grown in the absence (A, 8) and presence (C, D) 
of ORB (5,6-dichloro-o-ribofuranosylbenzimidazole) as described by Scheer et al. (1984). Cells were fixed and incubated with affinity 
purified monospecific anti-topoisomerase I antibodies raised in rabbit against enzyme purified from calf thymus and processed as described 
in Scheer and Rose (1984). A, C Phase contrast photomicrographs. 8 , D , Fluorescence photomicrographs. Inset in D , ORB-treated 
cells incubated with anti-RNA polymerase I antibodies 
ined the immunofluorescent pattern of topoisomerase I in 
cells treated with DRB. As shown in Figure 6D, the topo-
isomerase I appears as a series of tandemly arrayed dots, 
indistinguishable from the pattern obtained using anti -
RNA polymerase I antibodies which is shown in the inset 
for comparison. It should be noted that the antibodies 
against RNA polymerase I react predominantly with the 
M, 190000 polypeptide of the polymerase and that mono-
clonal antibodies against the M, 190000 subunit display an 
analogous pattern to those of the polyclonal antibodies. 
Other experiments using the anti-topoisomerase I anti-
bodies indicate that the enzyme can be located in the 
" caps " of segregated nucleoli of actinomycin D treated 
cells, in the fibrillar centers of nucleoli of tissue prepared 
for electron microscopy and at the nucleolar organizer re-
gions of metaphase chromosomes (not shown; see also 
Guldner et al. 1986). In no case can we distinguish the nuc-
leolar pattern from that using anti-RNA polymerase I anti-
bodies. It should be pointed out, however, that in contrast 
to the strict nucleolar location of RNA polymerase I, to po-
isomerase I is present both in the nucleolus and the nucleop-
lasm. As judged from immunofluorescence microscopy, the 
relative proportion of nucleolar and extranucleolar topo-
isomerase I seems to be quite variable in different cell types 
examined. 
Discussion 
Our data indicate that topoisomerase I can copurify with 
RNA polymerase I through a variety of ion exchange and 
affinity chromatography steps as well as sucrose gradient 
centrifugation or gel filtration steps which contain less than 
0.25 M (NH4hS04' That the association of the enzymes 
represents a true complex rather than simple copurification 
of the two enzymes is demonstrated by their ability to be 
reassociated following disassociation and separation. Fur-
ther, the complex of the two enzymes in vitro is sufficiently 
strong that anti -topoisomerase antibodies bound to the to-
poisomerase component of the complex can prevent tran-
scription or remove polymerase from solution. It should 
be noted that although the topoisomerase has an M, similar 
to one of the polymerase polypeptides, the topoisomerase 
does not significantly contribute to the mass of that poly-
merase polypeptide (less than 25%) and , indeed, polymera-
se I purified under stringent conditions still has a 
M,110000 polypeptide and no topoisomerase activity. 
Thus topoisomerase should be viewed as a polymerase-
binding enzyme rather than as a subunit. This idea is further 
strengthened by the fact that, at least on calf thymus DNA, 
topoisomerase activity is not required for transcription. 
The close association between topoisomerase and RNA 
polymerase I in vitro suggests a role for the topoisomerase 
in ribosomal gene transcription in vivo. This hypothesis 
is strongly supported by our observation that these two 
molecules can be immunocytochemically localized on the 
same structure in situ. In particular the colocalization of 
the two enzymes on the DRB-extended nucleolar chromatin 
provides direct evidence that the topoisomerase is found 
at the site of ribosomal RNA synthesis. While this manu-
script was under review, Zhang et al. (1988) published data 
implicating 'a role for topoisomerase 1 in ribosomal gene 
transcription in vivo. Taken together with the present study, 
416 
it seems highly likely that the action of this topoisomerase 
is required for proper synthesis of rRNA. 
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